Top Markets
Coin of the day
Atrion Corporation Atrion Corporation

Atrion Corporation

ATRI
Rank in Stocks #38752
Atrion Corporation, along with its affiliated entities, specializes in the... Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Share Price
$0.45992
Last synced: 2024-08-30
Market Cap
$821.42K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Atrion Corporation (ATRI)

Category

Revenue for Atrion Corporation (ATRI)
Revenue in Jun 2024 TTM: $181.60M
According to Atrion Corporation latest financial reports the company's current revenue (TTM) is $181.60M. In 2022 the company made a revenue of $183.51M an increase over the revenue in the year 2021 that was $165.01M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Atrion Corporation from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $181.60M 7.25%
2023 $169.33M -7.73%
2022 $183.51M 11.21%
2021 $165.01M 11.80%
2020 $147.59M -4.82%
2019 $155.07M 1.72%
2018 $152.45M 3.99%
2017 $146.60M 2.17%
2016 $143.49M -1.54%
2015 $145.73M 3.53%
2014 $140.76M 6.64%
2013 $131.99M 10.86%
2012 $119.06M 1.15%
2011 $117.70M 8.41%
2010 $108.57M 7.88%
2009 $100.64M 4.95%
2008 $95.90M 8.31%
2007 $88.54M 9.28%
2006 $81.02M 12.39%
2005 $72.09M 9.09%
2004 $66.08M 11.00%
2002 $59.53M 3.35%
2001 $57.61M 11.97%
2000 $51.45M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$11.03B 5,976.14%
US
$34.74B 19,027.85%
FR
- -
JP
$20.84B 11,375.09%
US
- -
CH